B+
Bull case
25%
Probability
Target price
$200.00
Analysis reference price unavailable
Analysis 2026-01-17 · RankAlpha Sentiment AI
BLTE
Belite BioDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$165.29
Analysis reference price unavailable
Analysis 2026-01-17 · RankAlpha Sentiment AI
B-
Bear case
15%
Probability
Target price
$85.00
Analysis reference price unavailable
Analysis 2026-01-17 · RankAlpha Sentiment AI
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-01-17
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+49.3
Score
AI commentary
Cautiously positive: analyst median sits above the anchor but the wide high/low dispersion signals binary event risk. Near-term focus on operational updates and clinical timelines implies event-driven volatility [#SERP-2][#SERP-1].
RankAlpha Sentiment AI - 2026-01-17
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-17catalystInvestor update / cash-runway disclosureHigh impact
Company update on cash runway or near-term operational milestones; no public date available so set to short-horizon default (as_of_date +90 days) [#IR-Update].
2026-10-01eventPlanned clinical readout (assumed window end)High impact
Assumed end-of-window for a pivotal/Phase 2 readout; date is estimated conservatively and noted as an assumption in absence of a public date [#PR-2026-10-01].
2027-01-17catalystPartnership / licensing or commercialization progressHigh impact
Potential business development or commercialization progress assumed over a multi‑quarter horizon; date set to long default (as_of_date +365 days) as conservative estimate [#BD-2027-01-17].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-17 • Updated nightlySource: Internal modelMethodology